ESI Normolip 5 Strong Cholesterol reducer 24.tabs - food supplement made from fermented rice

Description
Contributes to maintaining normal levels of cholesterol, triglycerides and lipids (Berberis aristata)

The nutritional supplement NORMOLIP 5 STRONG contains Berberis aristata extract, Red rice fermented from Monascus purpureus, Milk Thistle extract, Folic Acid, Coenzyme Q10, Chromium and Polycosanols. Berberine from Berberis aristata contributes to maintaining normal levels of cholesterol, plasma triglycerides, lipids and regulating the functionality of the cardiovascular system, while also contributing to skin health. Silymarin from milk thistle promotes detoxification and regeneration of the liver, heart health, bile secretion, cleansing functions of the body and acts as an antioxidant. Coenzyme Q10, essential for proper cell function, provides antioxidant protection. Folic acid contributes to normal hematopoiesis, normal immune system function, reduction of tiredness and fatigue, and normal homocysteine metabolism. Chromium contributes to the maintenance of normal blood glucose levels and the normal metabolism of macronutrients.

Ingredients Per 1 Tablet % RDA*
Berberis aristata tit 85% 588 mg
Berberine hydrochloride intake 500 mg
Milk thistle d.e. titer 80% 100 mg
Silymarin intake 80 mg
Red Rice from Monascus purpureus tit 5% total monacolins 58 mg
Total monacolins intake 2.9 mg
Coenzyme Q10 10 mg
Policosanol tit 60% 10 mg
Octacosanol intake 6 mg
Folic Acid (Folate) 200 mcg 100
Chromium 40 mcg 100
* Recommended Daily Dose

Excipients:
Microcrystalline cellulose, dicalcium phosphate, cross-linked sodium carboxymethylcellulose, hydroxypropylmethylcellulose, magnesium fatty acids, silicon dioxide.

Packaging: 24 tablets

Instructions for use:
Recommended Daily Dose: 1 tablet in the evening with a full glass of water or as directed by your doctor and for as long as necessary.

Does not contain:

Animal derivatives (suitable for vegetarians)
Gluten
Genetically modified organisms
Sugar

No. Acquaintance EOF: 70482/24.6.2022
The product is not subject to a licensing process.